reason report
dupont outlook
own cover time separ
even own dupont taken real
beat stock econom sensit dupont
portfolio value-add far econom sensit
trade-sensit expect pain
valuat stock look like higher qualiti recoveri play given
secular potenti
thesi dupont economi come slump
dupont far stronger compani one went
re-rat downward true earlier
time recoveri uncertain valuat point
pay specialti multipl anymor price target fall
rate remain overweight
reduc adj ep estim
respect
one old dupont key manag told investor
problem busi innov fast
exist product commodit warn come
mind today watch sever dupont still promis
busi get swamp market condit ev still
great opportun repres small part today portfolio
old stuff repres bulk portfolio get hit
hard today dupont prove far econom sensit
expect despit real secular growth potenti key
investor told us today sheer breadth weak
surpris know mani busi
could weak part function dupont describ
econom sensit year ago dupont told investor
portfolio softer quarter call earlier
dupont push back idea portfolio trade-
sensit tend describ dupont global play
portfolio broad divers true merger
true today surpris us breadth weak
magnitud thought busi would held
better consid modest
dupont develop market specialti chemic
sector electron nutrit bio-scienc
import disclosur analyst certif page report access current disclosur stephen
transport polym safeti construct
inc cover compani client may refer
electron imag still work macro issu
de-stock cycl taken longer expect
interconnect busi better semi even pretti strong smartphon product cycl dupont say turn
second-half event china uncertainti replac trade uncertainti risk volum remain signific
transport industri took biggest hit remain econom sensit view
result alreadi nylon price issu well-understood fulli reflect year guidanc
part segment particularli health care hold better think worst probabl happen right unless
enter deeper econom slump stock reaction today appear alreadi price continu slump
less concern weak safeti construct weak evid
slump appear get much wors meanwhil water side continu experi
nutrit bioscienc strong year even got slow start expect better
year anim protein anoth good year plant-bas altern probiot lose traction
well product like cbd grab headlin consum wallet yet scienc behind probiot although far
clear cut vastli stronger product like cbd supplement expect domest growth
pick oversea probiot growth stronger big health scare tend drive even higher supplement sale
new dupont perform much like old dupont would good deal restructur
cost reduct pace innov commerci enough off-set modestli weaker econom
condit probabl structur issu go go away particularli sale nutrit
bioscienc among highest growth least cyclic part portfolio differ revalu
 investor longer price breen premium expect larg capit return think dupont
quasi-commod cyclic stock get high valu portfolio attract price cycl alreadi
earli revalu dupont look like attract way play recoveri theme
investor patienc told remainco trade estim stock look wash
price target fall rate remain overweight
good sold
amort intang
add back dupont amort intang
total ebit exclud amort intang
net item
net inc item pref min int
analyst primarili respons prepar content report certifi view express report
accur reflect analyst person view subject compani secur ii part analyst compens
directli indirectli relat specif recommend view express analyst report
